Director/PDMR Shareholding

RNS Number : 0121G

Dechra Pharmaceuticals PLC

16 October 2008

 

Dechra Pharmaceuticals PLC 

(the Company)

 Directors / PDMR Sharedealing

16 October 2008

Dechra Pharmaceuticals PLC announces that, on 15 October 2008, the following Directors and PDMR's exercised options over ordinary shares of 1p each in the Company, granted to them on 3 October 2005 pursuant to the Dechra Pharmaceuticals Plc Long Term Incentive Plan (the LTIP), at an exercise price of £1 each: 

Name	Capacity	Options Exercised	Shares Sold	Sale Price per share	Total beneficial  shareholding following this announcement
Ian Page	Director	34,861	14,337	£4.00	779,856
Simon Evans	Director	23,904	0	0	830,274
Edwin Torr	Director	22,908	9,421	£4.00	440,283
Giles Coley	PDMR	14,940	6,145	£4.00	83,269
Mike Annice	PDMR	18,426	7,578	£4.00	659,830
Peter Graham	PDMR	15,936	6,554	£4.00	55,302
Mike Eldred	PDMR	38,308	15,370	£4.00	22,938

The exercise of the LTIP options were subject to the achievement of performance conditions which were satisfied in full.

All Directors (other than Simon Evans) and PDMR's have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

Enquiries:

Zoe Bamford

Company Secretary

01782 771100

 

END

 

 

RDSFKAKNDBDDFKD